Furthermore, genetic knockdown of LAMPs sensitizes artificially transformed cells to anti-cancer drugs (Fehrenbacher et al., 2008), and inhibiting trafficking of LAMPs to lysosomes activates the cathepsin-mediated lysosomal cell death pathway. Here, CTSS is linked to cancer.